Enliven Therapeutics logo

Enliven Therapeutics Share Price Today

(NASDAQ: ELVN)

Enliven Therapeutics share price is $21.25 & ₹1,848.09 as on 6 Mar 2025, 2.30 'hrs' IST

$21.25

1.33

(6.68%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Enliven Therapeutics share price in Dollar and Rupees. Guide to invest in Enliven Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Enliven Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Enliven Therapeutics share price movements

  • Today's Low: $19.85
    Today's High: $21.26

    Day's Volatility :6.63%

  • 52 Weeks Low: $10.90
    52 Weeks High: $30.03

    52 Weeks Volatility :63.7%

Enliven Therapeutics (ELVN) Returns

PeriodEnliven Therapeutics IncIndex (Russel 2000)
3 Months
-8.6%
0.0%
6 Months
-3.01%
0.0%
1 Year
37.54%
0.0%
3 Years
-10.53%
-11.6%

Enliven Therapeutics (ELVN) Key Statistics

in dollars & INR

Previous Close
$19.92
Open
$20.02
Today's High
$21.26
Today's Low
$19.85
Market Capitalization
$973.3M
Today's Volume
$277.8K
52 Week High
$30.03
52 Week Low
$10.9001
Revenue TTM
$0.0
EBITDA
$-98.8M
Earnings Per Share (EPS)
$-1.91
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-30.98%

How to invest in Enliven Therapeutics Stock (ELVN) from India?

It is very easy for Indian residents to invest directly in Enliven Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Enliven Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Enliven Therapeutics or ELVN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Enliven Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Enliven Therapeutics shares which would translate to 0.041 fractional shares of Enliven Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Enliven Therapeutics, in just a few clicks!

Returns in Enliven Therapeutics (ELVN) for Indian investors in Rupees

The Enliven Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Enliven Therapeutics investment value today

Current value as on today

₹1,42,489

Returns

₹42,489

(+42.49%)

Returns from Enliven Therapeutics Stock

₹37,540 (+37.54%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Enliven Therapeutics (ELVN)

300%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Enliven Therapeutics Stock from India on INDmoney has increased by 300% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Enliven Therapeutics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Enliven Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Enliven Therapeutics Stock (ELVN)

What analysts predicted

Upside of 78.15%

Target:

$37.86

Current:

$21.25

Insights on Enliven Therapeutics Stock (Ticker Symbol: ELVN)

  • Price Movement

    In the last 7 days, ELVN stock has moved up by 5.5%
  • ELVN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 29.0%

Enliven Therapeutics Technicals Summary

Sell

Neutral

Buy

Enliven Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Enliven Therapeutics (ELVN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Enliven Therapeutics Inc logo
-3.41%
-3.01%
37.54%
-10.53%
-10.53%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Enliven Therapeutics Inc logo
NA
NA
NA
-1.59
-0.31
-0.21
NA
6.1
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Enliven Therapeutics Inc logo
Buy
$973.3M
-10.53%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Enliven Therapeutics

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.
Organization
Enliven Therapeutics
Employees
57
CEO
Mr. Samuel S. Kintz M.B.A.
Industry
Miscellaneous

Management People of Enliven Therapeutics

NameTitle
Mr. Samuel S. Kintz M.B.A.
Co-Founder, CEO, Secretary & Director
Dr. Joseph P. Lyssikatos Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Helen Louise Collins M.D.
Chief Medical Officer
Mr. Anish Patel Pharm.D.
Co-Founder & COO
Mr. Benjamin Hohl
CFO & Head of Corporate Development
Dr. Galya D. Blachman Esq., Ph.D.
Chief Legal Officer & Head of Business Development

Important FAQs about investing in ELVN Stock from India :

What is Enliven Therapeutics share price today?

Enliven Therapeutics share price today stands at $21.25, Open: $20.02 ; Previous Close: $19.92 ; High: $21.26 ; Low: $19.85 ; 52 Week High: $30.03 ; 52 Week Low: $10.90.

The stock opens at $20.02, after a previous close of $19.92. The stock reached a daily high of $21.26 and a low of $19.85, with a 52-week high of $30.03 and a 52-week low of $10.90.

Can Indians buy Enliven Therapeutics shares?

Yes, Indians can invest in the Enliven Therapeutics (ELVN) from India.

With INDmoney, you can buy Enliven Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Enliven Therapeutics at zero transaction cost.

How can I buy Enliven Therapeutics shares from India?

It is very easy to buy Enliven Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Enliven Therapeutics (ELVN) be purchased?

Yes, you can buy fractional shares of Enliven Therapeutics with INDmoney app.

What are the documents required to start investing in Enliven Therapeutics stocks?

To start investing in Enliven Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Enliven Therapeutics Stock (ELVN)?

Today’s highest price of Enliven Therapeutics (ELVN) is $21.26.

Today’s lowest price of Enliven Therapeutics (ELVN) is $19.85.

What is today's market capitalisation of Enliven Therapeutics?

Today's market capitalisation of Enliven Therapeutics ELVN is 973.3M

What is the 52 Week High and Low Range of Enliven Therapeutics Stock (ELVN)?

  • 52 Week High

    $30.03

  • 52 Week Low

    $10.90

What are the historical returns of Enliven Therapeutics (ELVN)?

  • 1 Month Returns

    -3.41%

  • 3 Months Returns

    -3.01%

  • 1 Year Returns

    37.54%

  • 5 Years Returns

    -10.53%

Who is the Chief Executive Officer (CEO) of Enliven Therapeutics ?

Mr. Samuel S. Kintz M.B.A. is the current Chief Executive Officer (CEO) of Enliven Therapeutics.